EcoDrugPlus

Cholinergic Receptor Nicotinic Alpha 7 Subunit

Ensembl ID : ENSCMIG00000006098
Gene Symbol: CHRNA7
4 Cross references
254 Possible Orthologues:

Coagulation Factor Ii Thrombin Receptor

Ensembl ID : ENSCMIG00000001296
Gene Symbol: F2R
4 Cross references
329 Possible Orthologues:

Coagulation Factor X-Like

Ensembl ID : ENSCMIG00000011540
Gene Symbol: LOC103185529
4 Cross references
238 Possible Orthologues:

Coagulation Factor X-Like

Ensembl ID : ENSCMIG00000011535
Gene Symbol: LOC103185526
3 Cross references
238 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSCMIG00000019474
Gene Symbol: CCDC6
4 Cross references
223 Possible Orthologues:

Collagenase 3-Like

Ensembl ID : ENSCMIG00000005955
Gene Symbol: LOC103177581
2 Cross references
325 Possible Orthologues:

Complement C5

Ensembl ID : ENSCMIG00000013604
Gene Symbol: C5
2 Cross references
216 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSCMIG00000009674
Gene Symbol: CRHR1
3 Cross references
209 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSCMIG00000017119
Gene Symbol: CCND1
1 Cross references
282 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSCMIG00000019501
Gene Symbol: CDK1
3 Cross references
246 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSCMIG00000014892
Gene Symbol: CDK2
4 Cross references
203 Possible Orthologues:

Cyclin Dependent Kinase 4

Ensembl ID : ENSCMIG00000002063
Gene Symbol: CDK4
4 Cross references
239 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).